Ampullary adenocarcinoma is a cancer, which occurs in ampulla of Vater, which is the junction of bile and pancreatic ducts to the small intestine. It is divided into two broad categories intestinal and pancreaticobiliary and is defined under the ICD-10 code C24.1. Early detection is rather efficient.
The symptoms normally occur along with other digestive conditions, but may consist of:
This cause is the most ambiguous in most cases, but a number of risk factors have been separated:
Our specialization lies in the treatment and diagnosis of rare gastrointestinal malignancies including ampullary adenocarcinoma and delivering patient-centered and caring services. Our team, which is based in Houston, includes gastroenterologists, oncologists, surgeons and dietitians who will cooperate to assemble a treatment program, which can be minimally invasive endoscopic ampullectomy, Whipple surgery, tailored chemotherapy and nutritional support.
Ready to take the next step? Early evaluation is a key to better performance. You can today make a call or an appointment to have the expert care that you need.
We've successfully treated more than 1K patients, helping individuals improve their digestive health and overall well-being through expert, personalized care.
With over 20 years of experience, GastroDoxs has been a trusted provider of gastroenterology care, focusing on delivering the best outcomes for patients
The code of C24.1 according to ICD-10 is amputary adenocarcinoma and this is what is used to create a medical record and billing of an incident.
Blood tests, cross-sectional imaging (CT or MRI), and an endoscopic biopsy are typically used to test the ampulla of Vater tissue, to diagnose it.
Yes. The intestinal form has a potential treatment which can be completely removed through surgery upon its early diagnosis.
The tumor cells of the intestine that resemble the microscopic appearance of the small intestine lining may influence the treatment choices and the prognosis.
Yes. In GastroDoxs, Houston will have gastroenterologists, surgeons, oncologists, and dietitians with specialization in the treatment of ampullary adenocarcinoma.
No. It is extremely rare and it is less than one percent of the digestive-tract cancers.
The surgical risks may occur in the form of infection, bloody result or inability to empty gastric. They are complications which are not usually experienced where they are performed by qualified surgical surgeons.
Not always. The chemotherapy involves the identification of the cancer pathology and cancer stage. Your caregivers will advise you on the same in a team.
IMMEDIATELY seek medical attention in case of a jaundice (yellowing of the skin or eyes), pain or changing the color of the stool or urine in the abdomen.
Yes. We will offer personalized nutrition and constant support of the dietitian throughout the treatment, after and before the treatment to make sure you are strong and control side effects.